CStone Pharmaceuticals is committed to identifying and mitigating significant climate-related issues that may impact its operations. CStone Pharmaceuticals aims to achieve its carbon reduction targets by adopting greener practices and exploring new possibilities to achieve sustainable operations. The company’s latest filings mentioned the keywords 'Emissions' and 'Climate Change' most number of times.

During the reporting period, CStone Pharmaceuticals generated 506.30 tonnes of CO2e, an increase of about 11.94% compared to last year. In 2022, the company reported 0 Tonnes of CO2e Direct GHG emissions (Scope 1) and Indirect GHG emissions (Scope 2) at 506.30 Tonnes of CO2e. The company has identified the risks associated with climate change and is committed to reducing carbon emissions. CStone Pharmaceuticals has taken steps to reduce waste generation, electricity consumption, and water consumption. The company is also intent on maintaining or reducing greenhouse gas emissions, waste generation, electricity consumption, and water consumption with similar levels of operations.

CStone Pharmaceuticals has calculated its greenhouse gas emissions with reference to the HKEX's "How to prepare an ESG Report Appendix 2: Reporting Guidance on Environmental KPIs." The company has also invested in recycling and reprocessing products and has set predetermined operating procedures for recycling. The company is committed to turning climate change risks into opportunities for sustainable development.

In conclusion, CStone Pharmaceuticals is committed to mitigating climate change and reducing its carbon emissions. CStone Pharmaceuticals has taken steps to reduce waste generation, electricity consumption, and water consumption. The company is committed to turning climate change risks into opportunities for sustainable development.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Company Filings Analytics uses machine learning to uncover key insights and track sentiment across millions of regulatory filings and other corporate disclosures for thousands of companies representing the world’s largest industries. This analysis is combined with crucial details on strategic and investment priorities, innovation strategies, and CXO insights to provide comprehensive company profiles.